Q13451 (FKBP5_HUMAN) Homo sapiens (Human)

Peptidyl-prolyl cis-trans isomerase FKBP5 UniProtKBInterProSTRINGInteractive Modelling

457 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

97 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Human FKBP51 protein in complex with C-terminal peptide of Human HSP 90-alpha Heteromer
Q96HX7;
13-425
100SO4;
Cryo-EM structure of the GR-Hsp90-FKBP51 complex Heteromer
P04150; P07900;
13-421
100ATP;MG;DEX;
Cryo-EM structure of Hsp90:FKBP51:p23 closed-state complex Heteromer
P07900; Q15185;
13-421
100ANP;
Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR at low … Heteromer
P42345;
9-140
100RAP; 11×SO4;
Co-crystal structure of the PPIase domain of FKBP51, Rapamycin and the FRB fragment of mTOR Heteromer
P42345;
20-140
100RAP;
SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC Heteromer
P40337; Q15369; Q15370;
21-140
98.33XZW;
The Fk1 domain of FKBP51 in complex with (2S)-2-((1S,5R,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo…homo-2-mer16-140
99.2RR5;
Human FKBP5 proteinmonomer13-424
100SO4;
Structure of the Large FKBP-like Protein, FKBP51, Involved in Steroid Receptor Complexesmonomer33-412
99.72SO4;
Crystal structure of a fragment of FKBP51 comprising the Fk1 and Fk2 domainsmonomer13-254
100
Fk1 domain of FKBP51, crystal form VImonomer13-140
100
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet…monomer16-140
99.2RSB;
The Fk1 domain of FKBP51 in complex with Antascomicine Bmonomer16-140
99.2Y6Z;
Fk1 domain mutant A19T of FKBP51, crystal form IV, in presence of DMSOmonomer16-140
99.2DMS;
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH NICOTINAMIDEmonomer16-140
99.2CL;NA;NCA;
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p…monomer16-140
97.6UUI;
Exploration of Pipecolate Sulfonamides as Binders of the FK506-Binding Proteins 51 and 52: Complex …monomer16-140
99.20OS;
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-(3,5-dichlorophenyl)sulfinyl)-3-(pyridi…monomer16-140
97.6UT6;
Fk1 domain mutant A19T of FKBP51, crystal form IVmonomer16-140
99.2
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-5-(hydroxymet…monomer16-140
99.29QN;
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …monomer16-140
99.21KZ;
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-(2-methoxye…monomer16-140
99.2384;
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PYRIDONEmonomer16-140
99.2CL;NA;HRZ;
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[…monomer16-140
99.20MC;
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …monomer16-140
99.21KU;
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-3-[2-(3,4-dim…monomer16-140
99.23JP;
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 4-METHYLIMIDAZOLEmonomer16-140
99.2NA;4MZ;
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-(benzo[d]thiazol-6-ylsulfonyl)-5-(methoxymet…monomer16-140
99.2RQW;
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((R)-(3,5-dichlorophenyl)sulfonimidoyl)-3-(p…monomer16-140
97.6UUI;
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH (1R)…monomer16-140
99.20MD;
Complex of Fk506 with the Fk1 domain mutant A19T of FKBP51monomer16-140
99.2FK5;
Structure of the FK1 domain of the FKBP51 G64S variant in complex with SAFit1monomer16-140
96.8GY1;EPE;GOL;
Structure of the FK1 domain of the FKBP51 G64S variant in complex with (2R,5S,12R)-12-cyclohexyl-2-…monomer16-140
96.8S8N;
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH 2-PIPERIDONEmonomer16-140
99.2CL;NA;V1L;
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 63monomer16-140
97.6T5H;
Fk1 domain mutant A19T of FKBP51, crystal form IIImonomer16-140
99.2SCN;
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …monomer16-140
99.2JFK;
The Fk1 domain of FKBP51 in complex with (2'R,5'S,12'R)-12'-cyclohexyl-2'-[2-(3,4-dimethoxyphenyl)e…monomer16-140
99.2RTT;
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH IMIDAZOLEmonomer16-140
99.2CL;NA;IMD;
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …monomer16-140
99.21KY;
The Fk1 domain of FKBP51 in complex with iFit4monomer16-140
99.237K;
The Fk1 domain of FKBP51 in complex with the new synthetic ligand 2-(3-((R)-1-((S)-1-((S)-2-cyclohe…monomer16-140
99.25BG;
Fk1 domain mutant A19T of FKBP51, crystal form Imonomer16-140
99.21PE;
The FK1 domain of FKBP51 in complex with peptide-inhibitor hit DFPFVmonomer16-140
99.2
The Fk1 domain of FKBP51 in complex with SAFit1monomer16-140
97.6GY1;
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 64amonomer16-140
97.6T5B;
The Fk1 domain of FKBP51 in complex with iFit1monomer16-140
99.237L;GOL;NA;
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH HYDANTOINmonomer16-140
99.2HYN;NA;
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 35-(E)monomer16-140
97.6T58;IS8;
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[…monomer16-140
99.20MC;
EVALUATION OF SYNTHETIC FK506 ANALOGS AS LIGANDS FOR FKBP51 AND FKBP52: COMPLEX OF FKBP51 WITH {3-[…monomer16-140
99.2I63;
FKBP51FK1 F67E/K60Orn (i, i+7) in complex with SAFit1monomer16-140
94.4GY1;
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)propanoy…monomer16-140
97.6UCT;
FKBP51FK1 F67E/K58 (i, i+9) in complex with SAFit1monomer16-140
95.2GY1;
Fk1 domain of FKBP51, crystal form VIImonomer15-139
100CO3;
The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-(5-chlorothiophen-2-yl)-2-cyclohe…monomer16-140
97.6U83;
The Fk1 domain of FKBP51 in complex with 2-(3-((1R)-1-(((2S)-1-(2-cyclohexyl-2-(thiophen-2-yl)acety…monomer16-140
97.6U8C;
Evaluation of Synthetic FK506 Analogs as Ligands for the FK506-Binding Proteins 51 and 52: Complex …monomer16-140
99.20MD;
The FK1 domain of FKBP51 in complex with SAFit-analog 15imonomer16-140
97.6A1H7C;
Fk1 domain of FKBP51, crystal form IImonomer16-140
100
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 33-(Z)monomer16-140
97.6R3E;
Fk1 domain of FKBP51, crystal form Imonomer16-140
100
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)pent-4-e…monomer16-140
97.6UC0;
The FK1 domain of FKBP51 in complex with SAFit-analog 23amonomer16-140
97.6A1H68;
The FK1 domain of FKBP51 in complex with SAFit-analog 24emonomer16-140
97.6A1H7E;
The Fk1 domain of FKBP51 in complex with (S)-(R)-3-(3,4-dimethoxyphenyl)-1-(3-(2-morpholinoethoxy)p…monomer16-140
99.2L2Q;
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)-2-(3,4,…monomer16-140
97.6UCO;
CRYSTAL STRUCTURE OF HUMAN FKBP51 FK1 DOMAIN A19T MUTANT IN COMPLEX WITH SAFit2monomer16-140
99.237K;
The FK1 domain of FKBP51 in complex with SAFit-analog 15bmonomer16-140
97.6A1H7A;
The Fk1 domain of FKBP51 in complex with the new synthetic ligand (1R)-3-(3,4-dimethoxyphenyl)-1-f3…monomer16-140
99.25B8;
The FK1 domain of FKBP51 in complex with SAFit-analog 15hmonomer16-140
97.6A1H7B;
The FK1 domain of FKBP51 in complex with SAFit-analog 23bmonomer16-140
97.52A1H7F;
The FK1 domain of FKBP51 in complex with SAFit-analog 23dmonomer16-140
97.6A1H7D;
The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]…monomer16-139
99.19RTQ;
The FK1 domain of FKBP51 in complex with (1S,5S,6R)-10-((S)-3,5-dichloro-N-methylphenylsulfonimidoy…monomer16-139
97.58UMR;
Increasing the Efficiency Efficiency of Ligands for the FK506-Binding Protein 51 by Conformational …monomer16-139
99.191KT;DMS;GOL;
The Fk1 domain of FKBP51 in complex with ((1S,5S,6R)-10-((3,5-dichlorophenyl)sulfonyl)-2-oxo-5-viny…monomer16-139
99.19RRZ;
The FK1 domain of FKBP51 in complex with (3S,11S,11aS)-12-((3,5-dichlorophenyl)sulfonyl)-5-oxo-11-v…monomer16-139
97.58A1H70;
The FK1 domain of FKBP51 in complex with (3S,11S)-12-((3,5-dichlorophenyl)sulfonyl)-5-oxo-11-vinyld…monomer16-139
97.58A1H78;
Structure of the FK1 domain of the FKBP51 G64S variant in complex with (1S,5S,6R)-10-((3,5-dichloro…monomer16-139
96.779QN;
Complex of the Fk1 domain mutant A19T of FKBP51 with 4-Nitrophenolmonomer16-139
99.19NPO;
The Fk1 domain of FKBP51 in complex with (2R,5S,12S)-12-(thiophen-2-yl)-2-[2-(3,4-dimethoxyphenyl)e…monomer16-139
97.58UBK;
The FK1 domain of FKBP51 in complex with peptide-inhibitor hit SFPFTmonomer16-139
99.19
The Fk1 domain of FKBP51 in complex with (2R,5S,12R)-12-cyclohexyl-2-[2-(3,4-dimethoxyphenyl)ethyl]…monomer16-139
97.58S8N;
The Fk1 domain of FKBP51 in complex with 2-(3-((R)-1-(((S)-1-((S)-2-(5-chlorothiophen-2-yl)butanoyl…monomer16-139
97.5UCF;GOL;
The FK1 domain of FKBP51 in complex with peptide-inhibitor hit QFPFVmonomer16-139
99.19
Fk1 domain mutant A19T of FKBP51, crystal form IImonomer16-139
99.19
The Fk1 domain of FKBP51 in complex with the new synthetic ligand (S)-N-(1-carbamoylcyclopentyl)-1-…monomer16-139
99.195BH;
Fk1 domain of FKBP51, crystal form IIImonomer16-139
100
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 55monomer16-139
97.58S5W;
Fk1 domain of FKBP51, crystal form VIIImonomer16-139
100
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1R)-1,2-d…monomer17-139
99.193JQ;
The FK1 domain of FKBP51 in complex with SAFit-analog 23jmonomer19-140
97.54A1H7U;
Allosteric coupling of conformational transitions in the FK1 domain of FKBP51 near the site of ster…monomer20-140
99.17
The Fk1 domain of FKBP51 in complex with (1S,5S,6R)-10-[(3,5-dichlorophenyl)sulfonyl]-5-[(1S)-1,2-d…monomer19-139
99.173JR;
The FK1 domain of FKBP51 in complex with SAFit-analog 23cmonomer20-140
98.35A1H7G;
Structure of the FKBP51FK1 domain in complex with the macrocyclic SAFit analogue 56monomer22-139
98.31R3B;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5omp.1.Amonomer0.7913-424
100.00

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23o5d.1.Amonomer0.7713-234
95.28